松岡 義

Medicine & Life Sciences

1. Dissecting Aneurysm 100%
2. Emergencies 82%
3. Gases 53%
4. Thorax 52%
5. Esophagectomy 49%
6. Hydrogen 48%
7. Thoracic Aorta 41%
8. Aorta 41%
9. Retrospective Studies 40%
10. Inhalation 39%
11. 3-(4-(4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl)pyrrolidin-2-ylcarbonyl)thiazolidine 39%
12. Propensity Score 38%
13. Ventricular Septal Rupture 33%
14. Li-Fraumeni Syndrome 32%
15. Peritonitis 32%
16. Hemorrhagic Shock 32%
17. remnant-like particle cholesterol 31%
18. Spontaneous Perforation 31%
19. Esophageal Perforation 29%
20. Mesenteric Ischemia 28%
21. Glycocalyx 28%
22. Xanthine Dehydrogenase 28%
23. Dipeptidyl-Peptidase IV Inhibitors 27%
24. Resuscitation 26%
25. Thiamine 25%
26. Lung 25%
27. Extracorporeal Membrane Oxygenation 24%
28. Cardiogenic Shock 24%
29. Irritable Bowel Syndrome 24%
30. Bevacizumab 23%
31. Shock 23%
32. Dissection 22%
33. Enteral Nutrition 22%
34. Japan 21%
35. Rectal Neoplasms 21%
36. Portal Vein 21%
37. Combination Drug Therapy 21%
38. Acute Coronary Syndrome 21%
39. Stents 21%
40. Ascorbic Acid 20%
41. Abdominal Aorta 20%
42. Renal Dialysis 20%
43. Adrenal Cortex Hormones 20%
44. Operative Time 20%
45. Lipoproteins 20%
46. Blood Transfusion 19%
47. Chronic Renal Insufficiency 19%
48. Coronavirus 18%
49. Control Groups 18%
50. Cohort Studies 17%